Bloomberg Technology

‘Real Tech’ Built in Boston, Not Silicon Valley: Ginkgo Bioworks

May.11 — Ginkgo Bioworks Inc’s CEO Jason Kelly and Moderna Inc’s co-founder and chairman Noubar Afeyan discuss the rise of biotech companies in Boston and how the city drives so much innovation. They speak to Emily Chang on “Bloomberg Technology.”

Published

4 years ago

on

May.11 — Ginkgo Bioworks Inc’s CEO Jason Kelly and Moderna Inc’s co-founder and chairman Noubar Afeyan discuss the rise of biotech companies in Boston and how the city drives so much innovation. They speak to Emily Chang on “Bloomberg Technology.”

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version